Jnj competitors.

Dec 31, 2022 · Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2) The interval between Moderna doses is 28 days; for the Pfizer vaccine, it’s 21 days. Each dose of Pfizer’s contains 30 micrograms of vaccine. Moderna went with a much larger dose of vaccine ...Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected] it comes to luxury private jets, the Gulfstream G650 is often regarded as one of the best in its class. With its sleek design, advanced technology, and exceptional performance capabilities, this aircraft stands out from its competitors...

Working at Johnson & Johnson. Working at Johnson & Johnson is rated highly by 869 employees, across various culture dimensions. Johnson & Johnson employees are most satisfied about CEO Rating, Compensation, and Executive Team categories, putting Johnson & Johnson’s culture in the Top 20% compared to similar sized companies on Comparably and in the Top 30% compared to other companies in New York.In 2022, Johnson & Johnson's sales in the United States came to over 48 billion U.S. dollars. Thus, the largest part of the company’s revenue was generated in the United States. Europe is the ...Johnson & Johnson (NYSE:JNJ) EV/EBITDA ratio. See how EV/EBITDA has changed over time and compare its current value with the distribution of EV/EBITDA across competitors.

... JNJ and is also a component of the Dow Jones Industrial Average (DJIA). Competition and Market Share. As a healthcare conglomerate, Johnson & Johnson ...April 19, 2022. New Brunswick, N.J. (April 19, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2022. “Our first quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds. I am incredibly proud of Johnson & Johnson ’s 144,000 employees for their relentless passion ...

Beyond the glitz, the Brazilian Zouk World Championships serve as a platform for artists to showcase their dedication to dance. The competitors pour their hearts into their performances, expressing emotions and narratives through their movements. Each routine tells a unique story, capturing the essence of Zouk and leaving a lasting impression ...Comparison Analysis Based on SEC Data. Company Name. Johnson & Johnson. Industry (SIC) 2834 - Pharmaceutical Preparations. Revenue in 2022. $94,943 million (ranked #2 out of 645 companies in the industry) Assets as of 12/31/2022. $187,378 million (ranked #2)Johnson And Johnson Annual EBITDA Margin, current and historic annual results, over the past five years - CSIMarketThe average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. Learn more on JNJ's analyst rating history. Do Wall Street analysts like Johnson & Johnson more than its competitors?Johnson & Johnson researches, develops, manufactures, and sells products in health care. The company was founded by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, in New Brunswick, New Jersey, in 1886 (J&J website). Alex Gorsky is currently the chairman and chief executive officer of the company.

JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken. Corrective Wave being formed now. A wave is over. B wave to form this week. C wave may go up to the upper resistance level. Thereafter, JNJ to begin a long downtrend. Neckline of H&S pattern was broken. JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken.

Financial Glossary 7-Day Free Trial JNJ 0.81% GURUFOCUS.COM STOCK LIST …

Roughly 53 percent of sales came from abroad. Competitive advantage: Product: The first competitive advantage for JNJ lies in its product itself which has "NO MORE TEARS" formula patent. Safety, comfort, and gentleness have always been a top most priority in its products.Nov 12, 2021 ... ... rivals. image A French research-and-development lab for Johnson & Johnson in 2017. Photo: CHARLY TRIBALLEAU/AFP/Getty Images. The new company ...Johnson & Johnson Or Novo Nordisk: Which Is The Best Big Pharma Near Cap-Gainer Jun. 16, 2022 5:35 AM ET Johnson & Johnson (JNJ) NVO 11 Comments 9 Likes Peter F. Way, CFAJNJ reported $82.58 billion in revenue for the 2020 fiscal year—$43.13 billion from the United States while the remaining $39.45 billion came from international sources. Johnson & Johnson ...Dec 1, 2023 · In the previous week, Eli Lilly and Company had 11 more articles in the media than Novo Nordisk A/S. MarketBeat recorded 37 mentions for Eli Lilly and Company and 26 mentions for Novo Nordisk A/S. Eli Lilly and Company's average media sentiment score of 0.71 beat Novo Nordisk A/S's score of 0.20 indicating that Eli Lilly and Company is being referred to more favorably in the news media. JNJ Operating Income third quarter 2023 Y/Y Growth Comment: Johnson And Johnson reported decrease in Operating Income in the third quarter 2023 by -7.66% to $ 5,740.00 millions, from the same quarter in 2022. The decrease in the third quarter 2023 Johnson And Johnson's Operating Income compares unfavorably to the Company's average Operating …

Some of JNJ competitors such as Pfizer, Abbots, and Merck Co. whose resources are also significantly greater in the healthcare industry, put pressure on Johnson & Johnson through lower pricing, dropping cost, constantly design new products, or update existing products and services to meet customer's demand and bring new customers to the fold.This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment ...42.65. 33.08. Compare Johnson & Johnson (JNJ) to other companies with price, technicals, performance, and fundamentals comparison.Dec 1, 2023 · The main competitors of Johnson & Johnson include Pfizer (PFE), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Novo Nordisk A/S (NVO), Merck & Co., Inc. (MRK), AbbVie (ABBV), UnitedHealth Group (UNH), Novartis (NVS), AstraZeneca (AZN), and Thermo Fisher Scientific (TMO). These companies are all part of the "medical" sector. JNJ Sales vs. its Competitors Q3 2023 Comparing the current results to its …

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - …The following chart compares the dividend increases for PG and JNJ: The Procter & Gamble dividend increase was double that of Johnson & Johnson. It is not that JNJ's dividend increase was bad. In ...

Published October 28, 2016. The Procter & Gamble Company ( PG) and Unilever N.V. (UN) are in similar yet different situations. Both companies are cutting costs in order to drive earnings growth ...Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - …May 7, 2018 ... ... Johnson & Johnson top competitors; 10. Competitive Advantage ... When moving into a new geographical location, JnJ is always fallen subject to ...Johnson & Johnson: Competitors Share Discover information and data insights on …Due to inventory build up in the second quarter 2023, Johnson And Johnson's inventory turnover ratio sequentially decreased to 2.58 in the second quarter 2023, unsurprisingly, as the Johnson And Johnson markets continue to deteriorate, and JNJ's faces growing challenges to bring down its inventories. Johnson And Johnson's average inventory …JNJ competitors consist of Abbott Laboatories which make baby bottles and sooth aching joints, Eli Lilly which came out with the famous Prozac (which is an antidepressant). Another competitor is Novartis AG which is located in Switzerland but they have been attacking illnesses. JNJ is considerded a large cap since it is 159. 96 billion.Current and historical return on equity (ROE) values for Johnson & Johnson (JNJ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have …Johnson And Johnson's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2023 to a ratio of 5.97, this is below the company average, and notable indication of worsening business environment.Average collection period, for Johnson And Johnson's accounts receivable remained unchanged …Johnson & Johnson's worldwide business is divided into three segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. The Consumer segment manufactures and markets a broad range of products used in the baby and child care, skin care, oral and wound care and women's health care fields, as well as nutritional and over-the-counter ... Market capitalization of Johnson & Johnson (JNJ) Market cap: $381.26 Billion As of December 2023 Johnson & Johnson has a market cap of $381.26 Billion.This makes Johnson & Johnson the world's 21th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value …

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment ...

The Coca-Cola Company’s major competitors are PepsiCo, Dr Pepper Snapple Inc., Monster Beverage Corp., and Suntory Beverage & Food Ltd. Coca-Cola is the most popular and valuable beverage distributor.

Johnson & Johnson: Competitors Share Discover information and data insights on Johnson & Johnson's key competitors and market peers. Competitor comparison Pfizer Inc Headquarters United States of America No. of employees 83,000 Revenue $100.3B Entity type Public F. Hoffmann-La Roche Ltd Headquarters Switzerland No. of employees 103,613 Revenue We believe Bristol Myers Squibb stock (NYSE: BMY) is a better pick than its industry peer, Johnson & Johnson (NYSE: JNJ). J&J trades at a higher valuation of 4.4x trailing revenues, compared to 3 ...Jan 4, 2023 · 144,500+. Annual Revenue. $93.77 billion (FY 2021) Website. www.jnj.com. James Wood Johnson, Edward Mead Johnson, and Robert Wood Johnson founded J&J as a family business to serve people with healthcare products. After 130 years, J&J is now one of the leading healthcare industry companies. With over 120,000 employees in the company, J&J is ... Porter’s Five Forces Analysis of Johnson & Johnson covers the company’s competitive landscape as well as the factors affecting its sector. The analysis focuses on measuring the company’s position based on forces like threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and competitive rivalry.Sep 27, 2023 · The Top Johnson & Johnson competitors are Pfizer, Novartis, Glaxo Smith Kline, Bayer, Merck, Abbott, Roche and others. Johnson & Johnson is American multinational pharmaceutical and medical equipment, and consumer goods manufacturing company. It was established in the year 1886 and headquartered in New Jersey. Johnson And Johnson' Executive Officers and mambers of the Board - CSIMarketWe have all heard of Band-Aid, Tylenol, Benadryl and Johnson’s baby powder. We have never heard of the new made-up word Kenvue. But Kenvue will be the new corporate parent of these familiar ...Johnson & Johnson has innovative healthcare products and is a trusted brand. Johnson & Johnson STP Segmentation Health care segment. Target Market Mostly urban families and hospitals and clinics. Positioning Johnson & Johnson's promise to healthcare & personal hygiene consumer products. Johnson & Johnson Product Portfolio Brands: 1. Bedtime. 2 ...

JNJ EPS Net third quarter 2023 Y/Y Growth Comment: Johnson and Johnson achieved in the third quarter 2023, above Company average EPS Net surge of 507.74% year on year, to $ 10.21 . Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS Net growth. While Johnson And …JNJ had done something similar in previous disputes so I knew it was coming down the pike. Limiting the financial burden is a priority. Otherwise, it's open ended and you are like BP who paid $71B ...JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken. Corrective Wave being formed now. A wave is over. B wave to form this week. C wave may go up to the upper resistance level. Thereafter, JNJ to begin a long downtrend. Neckline of H&S pattern was broken. JNJ formed a 1-2-3-4-5 Motive Wave after the neckline was broken.Some of the competitors of Johnson & Johnson include Pfizer, Merck & …Instagram:https://instagram. bofa dividendhnoi stockstock tracking websiteinvestment for retirees According to the issued ratings of 14 analysts in the last year, the consensus rating for Johnson & Johnson stock is Hold based on the current 8 hold ratings and 6 buy ratings for JNJ. The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00. ex date dividendoncy stocktwits Johnson And Johnson's current Dividend, dividend pay out and yield comparisons to industry, sector, and S&P 500McNeil Consumer Healthcare, the JNJ subsidiary that markets Tylenol, was responsible for $2.1 billion of company's overall $47 billion in 2004 sales. Therefore, analysts don't expect a sales drop ... medical reits Johnson And Johnson's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2023 to a ratio of 5.97, this is below the company average, and notable indication of worsening business environment.Average collection period, for Johnson And Johnson's accounts receivable remained unchanged …Johnson & Johnson (XETRA:JNJ) EV/EBITDA ratio. See how EV/EBITDA has changed over time and compare its current value with the distribution of EV/EBITDA across competitors.Walmart is going head-to-head with Amazon with its new Walmart+ membership program set to launch later this month. In a challenge with Amazon, Walmart is expected to unveil its own membership shopping service later this month. Dubbed Walmar...